Medical Device Regulations and Testing for Toxicologic Pathologists
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Awareness of the regulatory environment is fundamental to understanding the biological assessment of biomaterials and medical devices. Medical devices are a diverse and heterogenous group of medical products and technologies defined by the lack of chemical action or requirement for metabolism. Regional activity and the Global Harmonization Task Force are now working on harmonizing the categorization and testing of medical devices. The International Organization for Standardization (ISO) has published 19 standards for biological evaluation. ISO 10993 standards are generally accepted outright or as an alternative to most national regulatory directives or acts, although Japan and the United States require more stringency in some tests. Type of materials, intended use, and risk are the basis for drafting testing programs for biomaterials and medical devices. With growth of the medical device industry and advent of new biomaterials and technologies, the need for toxicologic pathologists in safety (biocompatibility) and efficacy (conditions of use) evaluation of moderate- to high-risk devices is expanding. Preclinical evaluation of biomaterials and medical devices increasingly requires a basic understanding of materials science and bioengineering to facilitate interpretation of complex interface reactions between biomaterials, cellular and secretory factors, and vascular and tissue responses that modulate success or failure of medical devices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis
Patil, S. D., Papadmitrakopoulos, F., & Burgess, D. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.013 · Cited by 230 · cited 1×
“Localized elution of anti-inflammatory corticosteroids and vascular growth factor at implants has recently been shown to downregulate the foreign body response but also delay the reparative phase and negatively affect device function (Patil et al., 2007).”
Background
Cited by
Ramot, Y., Rotkopf, S., Gabai, R. M., Zorde Khvalevsky, E., Muravnik, S., Marzoli, G. A., Domb, A. J., Shemi, A., & Nyska, A. (2016) · Toxicologic Pathology · doi:10.1177/0192623316645860 · Cited by 64
“The capsule formation typically composed of a relatively thin mature fibrotic tissue, which was of comparable thickness in all these groups, as well as without any evidence of chronic active inflammation, necrosis, and/or mineralization, which may suggest potential adverse effects (Northup 1999; Nyska et al. 2014; Onu…”
BackgroundRamot, Y., Nyska, A., Markovitz, E., Dekel, A., Klaiman, G., Zada, M. H., Domb, A. J., & Maronpot, R. R. (2015) · Toxicologic Pathology · doi:10.1177/0192623315600275 · Cited by 55
Exploring rabbit as a nonrodent species for general toxicology studies
Sokolowski, K., Turner, P. V., Lewis, E., Wange, R. L., & Fortin, M. C. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae022 · Cited by 17
Greaves, P. (2012) · Histopathology of Preclinical Toxicity Studies · doi:10.1016/b978-0-444-53856-7.00002-6 · Cited by 5
Metadata
- Authors
- Schuh, J. C. L.
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2008-01
- Volume
- 36
- Issue
- 1
- Pages
- 63-69
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2136057637
- Cited by
- 62
- References
- 1
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.